Ronald H. Goldfarb - Publications

University of North Texas Health Science Center at Fort Worth 
Immunology, Microbiology Biology

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Edsparr K, Basse PH, Goldfarb RH, Albertsson P. Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 4: 351-60. PMID 22161319 DOI: 10.1007/s12307-010-0057-0  0.96
2011 Rastelli L, Valentino ML, Minderman MC, Landin J, Malyankar UM, Lescoe MK, Kitson R, Brunson K, Souan L, Forenza S, Goldfarb RH, Rabbani SA. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo. International Journal of Oncology. 39: 401-8. PMID 21567086 DOI: 10.3892/ijo.2011.1040  0.96
2010 Edsparr K, Speetjens FM, Mulder-Stapel A, Goldfarb RH, Basse PH, Lennernäs B, Kuppen PJ, Albertsson P. Effects of IL-2 on MMP expression in freshly isolated human NK cells and the IL-2-independent NK cell line YT. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 475-81. PMID 20463600 DOI: 10.1097/CJI.0b013e3181d372a0  0.96
2009 Edsparr K, Johansson BR, Goldfarb RH, Basse PH, Nannmark U, Speetjens FM, Kuppen PJ, Lennernäs B, Albertsson P. Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression. Immunology and Cell Biology. 87: 489-95. PMID 19434071 DOI: 10.1038/icb.2009.35  0.96
2007 Albertsson P, Basse PH, Edsparr K, Kim MH, Goldfarb RH, Golfarb RH, Kitson RP, Lennernäs B, Nannmark U, Johansson BR. Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix environment. Scandinavian Journal of Immunology. 66: 402-9. PMID 17850584 DOI: 10.1111/j.1365-3083.2007.01956.x  0.64
2006 Lu M, Dou QP, Kitson RP, Smith DM, Goldfarb RH. Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cells. Journal of Cellular Biochemistry. 97: 122-34. PMID 16173095 DOI: 10.1002/jcb.20543  0.96
2004 Gellert GC, Goldfarb RH, Kitson RP. Physical association of uPAR with the alphaV integrin on the surface of human NK cells. Biochemical and Biophysical Research Communications. 315: 1025-32. PMID 14985115 DOI: 10.1016/j.bbrc.2004.01.163  0.96
2004 Reshetnyak YK, Kitson RP, Lu M, Goldfarb RH. Conformational and enzymatic changes of 20S proteasome of rat natural killer cells induced by mono- and divalent cations. Journal of Structural Biology. 145: 263-71. PMID 14960377 DOI: 10.1016/j.jsb.2003.11.001  0.96
2003 Johnson LA, Vaidya SV, Goldfarb RH, Mathew PA. 2B4(CD244)-mediated activation of NK cells reduces metastases of B16F10 melanoma in mice. Anticancer Research. 23: 3651-5. PMID 14666660  0.96
2003 Albertsson PA, Basse PH, Hokland M, Goldfarb RH, Nagelkerke JF, Nannmark U, Kuppen PJ. NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends in Immunology. 24: 603-9. PMID 14596885 DOI: 10.1016/  0.96
2003 Yang Q, Hokland ME, Bryant JL, Zhang Y, Nannmark U, Watkins SC, Goldfarb RH, Herberman RB, Basse PH. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. International Journal of Cancer. Journal International Du Cancer. 105: 512-9. PMID 12712443 DOI: 10.1002/ijc.11119  0.96
2003 Gellert GC, Kitson RP, Goldfarb RH. Urokinase-type plasminogen activator receptor crosslinking in an NK cell line increases integrin surface expression by the MAP kinase/ERK 1/2 signaling pathway. Journal of Cellular Biochemistry. 89: 279-88. PMID 12704791 DOI: 10.1002/jcb.10512  0.96
2003 Lu M, Kitson RP, Xue Y, Goldfarb RH. Activation of multiple caspases and modification of cell surface fas (CD95) in proteasome inhibitor-induced apoptosis of rat natural killer cells. Journal of Cellular Biochemistry. 88: 482-92. PMID 12532325 DOI: 10.1002/jcb.10296  0.96
2002 Andreev OA, Reshetnyak YK, Goldfarb RH. Evidence of inter- and intra-molecular crosslinking of tyrosine residues of calmodulin induced by photo-activation of ruthenium(II). Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 1: 834-6. PMID 12656487 DOI: 10.1039/b201474b  0.96
2002 Kim MH, Gutierrez AM, Goldfarb RH. Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion. Anticancer Research. 22: 3811-7. PMID 12552999  0.96
2002 Datta A, Kitson RP, Xue Y, al-Atrash G, Mazar AP, Jones TR, Goldfarb RH. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases. In Vivo (Athens, Greece). 16: 451-7. PMID 12494889  0.96
2002 Chen WS, Kitson RP, Goldfarb RH. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). In Vivo (Athens, Greece). 16: 439-45. PMID 12494887  0.96
2002 Al-Atrash G, Shetty S, Idell S, Xue Y, Kitson RP, Halady PK, Goldfarb RH. IL-2-mediated upregulation of uPA and uPAR in natural killer cells. Biochemical and Biophysical Research Communications. 292: 184-9. PMID 11890690 DOI: 10.1006/bbrc.2002.6627  0.96
2002 Dou QP, Goldfarb RH. Bortezomib Millennium Pharmaceuticals Idrugs. 5: 828-834.  0.96
2001 Al-Atrash G, Kitson RP, Xue Y, Mazar AP, Kim MH, Goldfarb RH. uPA and uPAR contribute to NK cell invasion through the extracellular matrix. Anticancer Research. 21: 1697-704. PMID 11497249  0.96
2001 Kim MH, Albertsson P, Xue Y, Nannmark U, Kitson RP, Goldfarb RH. Expression of neutrophil collagenase (MMP-8) in Jurkat T leukemia cells and its role in invasion. Anticancer Research. 21: 45-50. PMID 11299777  0.96
2001 Kuppen PJ, van der Eb MM, Jonges LE, Hagenaars M, Hokland ME, Nannmark U, Goldfarb RH, Basse PH, Fleuren GJ, Hoeben RC, van de Velde CJ. Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochemistry and Cell Biology. 115: 67-72. PMID 11219610  0.96
2000 Nannmark U, Hokland ME, Agger R, Christiansen M, Kjaergaard J, Goldfarb RH, Bagge U, Unger M, Johansson BR, Albertsson PA, Basse PH. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells. In Vivo (Athens, Greece). 14: 651-8. PMID 11125549  0.96
2000 Johnson LA, Goldfarb RH, Mathew PA. Regulation of IFN-gamma production following 2B4 activation in human NK cells. In Vivo (Athens, Greece). 14: 625-9. PMID 11125547  0.96
2000 al-Atrash G, Kitson RP, Xue Y, Goldfarb RH. Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion. In Vivo (Athens, Greece). 14: 565-70. PMID 11125540  0.96
2000 Kim MH, Albertsson P, Xue Y, Kitson RP, Nannmark U, Goldfarb RH. Expression of matrix metalloproteinases and their inhibitors by rat NK cells: inhibition of their expression by genistein. In Vivo (Athens, Greece). 14: 557-64. PMID 11125539  0.96
2000 Chuang SS, Kim MH, Johnson LA, Albertsson P, Kitson RP, Nannmark U, Goldfarb RH, Mathew PA. 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology. 100: 378-83. PMID 10929061 DOI: 10.1046/j.1365-2567.2000.00031.x  0.96
2000 Guo Y, Higazi AA, Arakelian A, Sachais BS, Cines D, Goldfarb RH, Jones TR, Kwaan H, Mazar AP, Rabbani SA. A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 14: 1400-10. PMID 10877833  0.96
2000 Demetrikopoulos MK, Goldfarb RH, Zhang ZB, Weiss JM. Blood level of B and CD4+ lymphocytes measured before induction of an experimental tumor in rats predicts tumor progression and survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 9: 609-17. PMID 10868697  0.96
2000 Kim MH, Kitson RP, Albertsson P, Nannmark U, Basse PH, Kuppen PJ, Hokland ME, Goldfarb RH. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. Journal of Immunology (Baltimore, Md. : 1950). 164: 5883-9. PMID 10820269  0.96
2000 Albertsson P, Kim MH, Jonges LE, Kitson RP, Kuppen PJ, Johansson BR, Nannmark U, Goldfarb RH. Matrix metalloproteinases of human NK cells. In Vivo (Athens, Greece). 14: 269-76. PMID 10757086  0.96
2000 Kitson RP, Lu M, Siman R, Goldfarb RH. Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domains. In Vivo (Athens, Greece). 14: 265-8. PMID 10757085  0.96
2000 Goldfarb RH, Koelemij R, Muirhead KA, Ohlsson-Wilhelm BM, Gray BD, Kuppen PJ, Basse PH, al-Atrash G, Kitson RP. A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin. In Vivo (Athens, Greece). 14: 101-4. PMID 10757065  0.96
1999 Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis. 3: 15-32. PMID 14517441  0.96
1999 Goldfarb RH, Kitson RP, Brunson KW, Yoshino K, Hirota N, Kirii Y, Kotera Y, Inoue Y, Ohashi M. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles. Anticancer Research. 19: 1663-7. PMID 10470098  0.96
1999 Welch WC, Kornblith PL, Michalopoulos GK, Petersen BE, Beedle A, Gollin SM, Goldfarb RH. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells. Anticancer Research. 19: 1635-40. PMID 10470094  0.96
1999 Quan N, Zhang Z, Demetrikopoulos MK, Kitson RP, Chambers WH, Goldfarb RH, Weiss JM. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat. Cancer Research. 59: 1080-9. PMID 10070966  0.96
1998 An B, Goldfarb RH, Siman R, Dou QP. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death and Differentiation. 5: 1062-75. PMID 9894613 DOI: 10.1038/sj.cdd.4400436  0.96
1998 Kitson RP, Ohashi M, Brunson KW, Goldfarb RH. Flavone acetic acid enhances accumulation of IL-2 activated NK cells within established metastases. In Vivo (Athens, Greece). 12: 593-7. PMID 9891222  0.96
1998 Goldfarb RH, Albertsson P, Nannmark U, Kitson RP. Cytolytic activities of IL-2 activated NK cells from MMTV/v-Ha-ras transgenic oncomice during tumor progression. In Vivo (Athens, Greece). 12: 589-92. PMID 9891221  0.96
1998 Goldfarb RH, Ohashi M, Brunson KW, Kirii Y, Kotera Y, Basse PH, Kitson RP. Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide. Anticancer Research. 18: 1441-6. PMID 9673353  0.96
1998 Kitson RP, Appasamy PM, Nannmark U, Albertsson P, Gabauer MK, Goldfarb RH. Matrix metalloproteinases produced by rat IL-2-activated NK cells. Journal of Immunology (Baltimore, Md. : 1950). 160: 4248-53. PMID 9574526  0.96
1997 Ribeiro U, Basse PH, Rosenstein M, Safatle-Ribeiro AV, Alhallak S, Goldfarb RH, Posner MC. Retention of adoptively transferred interleukin-2-activated natural killer cells in tumor tissue. Anticancer Research. 17: 1115-23. PMID 9137458  0.96
1997 McEwen BS, Biron CA, Brunson KW, Bulloch K, Chambers WH, Dhabhar FS, Goldfarb RH, Kitson RP, Miller AH, Spencer RL, Weiss JM. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Research. Brain Research Reviews. 23: 79-133. PMID 9063588 DOI: 10.1016/S0165-0173(96)00012-4  0.96
1996 Nannmark U, Kitson RP, Johansson BR, Rivett AJ, Goldfarb RH. Immunocytochemical localization of multicatalytic protease complex (proteasome) during generation of murine IL-2-activated natural killer (A-NK) cells. European Journal of Cell Biology. 71: 402-8. PMID 8980912  0.96
1996 Bodey B, Kaiser HE, Goldfarb RH. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy. Anticancer Research. 16: 517-31. PMID 8615665  0.96
1996 Saxena RK, Saxena QB, Whiteside TL, Goldfarb RH, Herberman RB. Partial purification and characterization of a novel human factor that augments the expression of class I MHC antigens on tumour cells Journal of Biosciences. 21: 13-25. DOI: 10.1007/BF02716809  0.96
1996 Saxena QB, Saxena RK, Goldfarb RH, Herberman RB, Whiteside TL. Identification and partial purification of a human natural killer cell proliferation-inducing factor Journal of Biosciences. 21: 455-469. DOI: 10.1007/BF02703210  0.96
1995 Kitson RP, Miller CA, Goldfarb RH. Non-granular proteolytic enzymes of rat interleukin-2-activated natural killer cells. III. Enhancement of A-NKP 1, 2, and 3 proteolytic activities (cleaving after Arg, Phe and Pro) in response to interleukin-2. Natural Immunity. 14: 286-94. PMID 8933822  0.96
1995 Welch WC, Morrison RS, Gross JL, Gollin SM, Kitson RB, Goldfarb RH, Giuliano KA, Bradley MK, Kornblith PL. Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19. In Vitro Cellular & Developmental Biology. Animal. 31: 610-6. PMID 8528516 DOI: 10.1007/BF02634314  0.96
1995 Mars WM, Liu ML, Kitson RP, Goldfarb RH, Gabauer MK, Michalopoulos GK. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration Hepatology. 21: 1695-1701. PMID 7768515 DOI: 10.1016/0270-9139(95)90477-8  0.96
1995 Nannmark U, Johansson BR, Bryant JL, Unger ML, Hokland ME, Goldfarb RH, Basse PH. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Research. 55: 4627-32. PMID 7553640  0.96
1994 Goldfarb RH, Whiteside TL, Basse PH, Lin WC, Vujanovic N, Herberman RB. Natural killer cells and gene therapy: Potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases Natural Immunity. 13: 131-140. PMID 8173234  0.96
1994 Kuppen PJK, Basse PH, Goldfarb RH, Van de Velde CJH, Fleuren GJ, Eggermont AMM. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats International Journal of Cancer. 56: 574-579. PMID 8112894  0.96
1994 Wasserman K, Kitson RP, Rivett AJ, Sweeney ST, Gabauer MK, Herberman RB, Watkins SC, Goldfarb RH. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex. Journal of Cellular Biochemistry. 55: 133-45. PMID 8083294 DOI: 10.1002/jcb.240550115  0.96
1994 Brunson KW, Ohashi M, Miller CA, Kitson RP, Basse PH, Goldfarb RH. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: Binding to microvascular endothelial cells and BRM enhancement of cytolytic activity In Vivo. 8: 71-75. PMID 8054514  0.96
1994 Wasserman K, Kitson RP, Gabauer MK, Miller CA, Herberman RB, Goldfarb RH. Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells. In Vivo (Athens, Greece). 8: 33-41. PMID 8054509  0.96
1994 Basse PH, Goldfarb RH, Herberman RB, Hokland ME. Accumulation of adoptively transferred A-NK cells in murine metastases: Kinetics and role of interleukin-2 In Vivo. 8: 17-24. PMID 8054506  0.96
1994 Kitson RP, Wasserman K, Goldfarb RH. Identification and enrichment of proteolytic enzymes of IL-2 activated rat natural killer (A-NK) cells: potential physiological roles in NK cell function. Immunology Series. 61: 83-92. PMID 8011759  0.96
1994 Whiteside TL, Goldfarb RH. Immunomodulation and antitumor mechanisms. Introduction Immunology Series. 61: 179-181. PMID 8011742  0.96
1994 Whiteside TL, Goldfarb RH. Antitumor effector cells: extravasation and control of metastasis Immunology Series. 61: 159-173. PMID 8011740  0.96
1994 Basse P, Goldfarb RH. Localization of immune effector cells to tumor metastases Immunology Series. 61: 149-158. PMID 8011739  0.96
1994 Kitson RP, Brunson KW, Miller CA, Goldfarb RH. Neuroendocrine modulation of tumor metastases - I: Effect of adrenalectomy on B16 melanoma metastases In Vivo. 8: 803-806. PMID 7727728  0.96
1993 Goldfarb RH, Kornblith PL. Preface: Tumor invasion and brain cancer Journal of Neuro-Oncology. 18. DOI: 10.1007/BF01050414  0.96
1992 Basse P, Herberman RB, Hokland M, Goldfarb RH. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels Cancer Immunology Immunotherapy. 34: 221-227. PMID 1537054 DOI: 10.1007/BF01741789  0.96
1992 Goldfarb RH, Wasserman K, Herberman RB, Kitson RP. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role. Journal of Immunology (Baltimore, Md. : 1950). 149: 2061-8. PMID 1517570  0.96
1992 Basse PH, Herberman RB, Hokland ME, Goldfarb RH. Tissue distribution of adoptively transferred adherent LAK cells: Role of the route of administration Natural Immunity. 11: 193-202. PMID 1421955  0.96
1992 Goldfarb RH, Brunson KW. Therapeutic agents for treatment of established metastases and inhibitors of metastatic spread: Preclinical and clinical progress Current Opinion in Oncology. 4: 1130-1141. PMID 1281001  0.96
1992 Basse P, Herberman RB, Hokland M, Goldfarb RH. Reply to the Letter to the editors by A. Maghazachi Cancer Immunology Immunotherapy. 35: 428-430. DOI: 10.1007/BF01789024  0.96
1991 Basse PH, Nannmark U, Johansson BR, Herberman RB, Goldfarb RH. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells Journal of the National Cancer Institute. 83: 944-950. PMID 2067037 DOI: 10.1093/jnci/83.13.944  0.96
1991 Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. The Journal of Experimental Medicine. 174: 479-88. PMID 1856630  0.96
1989 Sasaki A, Jain RK, Maehazachi AA, Goldfarb RH, Herberman RB. Low Deformability of Lymphokine-activated Killer Cells as a Possible Determinant of in Vivo Distribution Cancer Research. 49: 3742-3746. PMID 2500233  0.96
1988 Gorelik E, Gunji Y, Goldfarb RH. Interaction of tumor cells and immune system in the metastatic process Biochemistry and Cell Biology. 66: 617-625. PMID 3048334  0.96
1988 Al Maghazachi A, Goldfarb RH, Herberman RB. Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution Journal of Immunology. 141: 4039-4046. PMID 2846699  0.96
1987 Wong RL, Gutowski JK, Katz M, Goldfarb RH, Cohen S. Induction of DNA synthesis in isolated nuclei by cytoplasmic factors: Inhibition by protease inhibitors Proceedings of the National Academy of Sciences of the United States of America. 84: 241-245. PMID 3540956 DOI: 10.1073/pnas.84.1.241  0.96
1986 Goldfarb RH. Role of neutral serine proteases in tumor cell lysis by natural killer cells (large granular lymphocytes) and activated macrophages Seminars in Thrombosis and Hemostasis. 12: 308-309. PMID 3538423  0.96
1986 Goldfarb RH. Cell-mediated cytotoxic reactions Human Pathology. 17: 138-145. PMID 3512410 DOI: 10.1016/S0046-8177(86)80286-6  0.96
1986 Goldfarb RH, Liotta LA. Proteolytic enzymes in cancer invasion and metastasis Seminars in Thrombosis and Hemostasis. 12: 294-307. PMID 3024322  0.96
1986 Goldfarb RH, Liotta LA. Thrombin cleavage of extracellular matrix proteins Annals of the New York Academy of Sciences. 288-292. PMID 2952037  0.96
1986 Goldfarb RH, Murano G, Brundage R, Siegal GP, Terranova V, Garbisa S, Liotta LA. Degradation of glycoprotein and collagenous components of the basement membrane: Studies with urokinase-type plasminogen activator, α-thrombin, and plasmin Seminars in Thrombosis and Hemostasis. 12: 335-336. PMID 2947330 DOI: 10.1055/s-2007-1003576  0.96
1986 Goldfarb RH, Ziche M, Murano G, Liotta LA. Plasminogen activators (urokinase) mediate neovascularization: Possible role in tumor angiogenesis Seminars in Thrombosis and Hemostasis. 12: 337-338. PMID 2431485  0.96
1984 Goldfarb RH, Timonen T, Herberman RB. Production of plasminogen activator by human natural killer cells. Large granular lymphocytes Journal of Experimental Medicine. 159: 935-951. PMID 6199454  0.96
1983 Jones CM, Goldfarb RH, Holden HT. Macrophage cell lines behave as activated macrophages in the production and regulation of plasminogen activator Cancer Investigation. 1: 207-213. PMID 6686788 DOI: 10.3109/07357908309041360  0.96
1983 Jetten AM, Goldfarb RH. Action of epidermal growth factor and retinoids on anchorage-dependent and-independent growth of nontransformed rat kidney cells Cancer Research. 43: 2094-2099. PMID 6299539  0.96
1983 Goldfarb RH, Berendt MJ. Chapter 27. Natural Killer Cells: Role in Cell-Mediated Immunity Annual Reports in Medicinal Chemistry. 18: 265-273. DOI: 10.1016/S0065-7743(08)60782-4  0.96
1983 Goldfarb RH. Chapter 26. Plasminogen Activators Annual Reports in Medicinal Chemistry. 18: 257-264. DOI: 10.1016/S0065-7743(08)60781-2  0.96
1982 Rao CN, Margulies IMK, Goldfarb RH, Madri JA, Woodley DT, Liotta LA. Differential proteolytic susceptibility of laminin alpha and beta subunits Archives of Biochemistry and Biophysics. 219: 65-70. PMID 6758704 DOI: 10.1016/0003-9861(82)90134-5  0.96
1982 Goldfarb RH, Timonen T, Herberman RB. Mechanism of tumor cell lysis by natural killer cells Advances in Experimental Medicine and Biology. 146: 403-421. PMID 6285682  0.96
1981 Hoffman T, Hirata F, Bougnoux P, Fraser BA, Goldfarb RH, Herberman RB, Axelrod J. Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. 78: 3839-43. PMID 6943585 DOI: 10.1073/pnas.78.6.3839  0.96
1981 Liotta LA, Brundage R, Siegal GP, Goldfarb RH, Terranova V, Garbisa S. Effect of Plasminogen Activator (Urokinase), Piasmin, and Thrombin on Glycoprotein and Collagenous Components of Basement Membrane Cancer Research. 41: 4629-4636. PMID 6458354  0.96
1981 Liotta LA, Goldfarb RH, Terranova VP. Cleavage of laminin by thrombin and plasmin: Alpha thrombin selectively cleaves the beta chain of laminin Thrombosis Research. 21: 663-673. PMID 6455777 DOI: 10.1016/0049-3848(81)90268-1  0.96
1981 Goldfarb RH, Herberman RB. Natural killer cell reactivity: Regulatory interactions among phorbol ester, interferon, cholera toxin, and retinoic acid Journal of Immunology. 126: 2129-2135. PMID 6164721  0.96
1981 Goldfarb RH, Herberman RB. Effect of phorbol 12-myristate 13-acetate (PMA), Cholera toxin (Chtx) and retinoic acid (RA) on spontaneous and interferon (IFN) augmented natural killer (NK) cell activity Federation Proceedings. 40.  0.96
1981 Goldfarb RH, Liotta LA, Garbisa S. Degradation of basement membrane components: Effects of plasminogen activator, plasmin, and αthrombin Proceedings of the American Association For Cancer Research. 59.  0.96
1980 Goldfarb RH, Quigley JP. Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate Biochemistry. 19: 5463-5471. PMID 6257279 DOI: 10.1021/bi00565a001  0.96
1980 Quigley JP, Goldfarb RH, Scheiner C, O'Donnell-Tormey J, Yeo TK. Plasminogen activator and the membrane of transformed cells. Progress in Clinical and Biological Research. 41: 773-96. PMID 6256777  0.96
1978 Goldfarb RH, Quigley JP. Synergistic Effect of Tumor Virus Transformation and Tumor Promoter Treatment on the Production of Plasminogen Activator by Chick Embryo Fibroblasts Cancer Research. 38: 4601-4609. PMID 214228  0.96
1978 Quigley JP, Goldfarb RH. Morphological changes induced by endogenous protease activity in cultures of phorbol ester treated RSV-transformed chick fibroblasts: evidence for direct proteolytic activity of plasminogen activator Journal of Cell Biology. 79.  0.96
1971 Sweeny A, Goldfarb RH, Salmon TN, Loewengart G, Fox R, Sicignano A. Some halogenated acetyl derivatives and their antitumor activity Journal of Medicinal Chemistry. 14: 451-452. PMID 5117695  0.96
Show low-probability matches.